Inserm, U1235, 44035, Nantes, France.
University Nantes, 44093, Nantes, France.
J Neurol. 2018 Apr;265(4):933-941. doi: 10.1007/s00415-018-8789-8. Epub 2018 Feb 20.
Dysautonomic symptoms are frequent non-motor complaints in patients with Parkinson's disease. Numerous neuropathological studies have shown that Lewy bodies and neurites, the pathological hallmarks of Parkinson's disease, are widely distributed throughout the peripheral autonomic nervous systems and across end organs. However, few investigations integrally explored the symptoms and physiology of dysautonomia in Parkinson's disease. We, therefore, performed a comprehensive evaluation of the autonomic function in a prospective group of 45 patients with idiopathic Parkinson's disease. Autonomic components (pupillomotor, tear, salivary, cardiovascular, digestive, urinary, sexual, sudomotor functions and skin sensitivity) were evaluated using questionnaires and functional tests. Skin biopsy was performed for intraepidermal nerve fibre density quantification. In addition, all patients underwent polysomnography and a complete neuropsychological and neurological assessment. The analysis association of autonomic components showed that dysautonomic signs and symptoms were heterogeneously distributed among patients. Skin denervation as assessed by intraepidermal nerve fibre density quantification was only associated with quantitative thermal sensory testing (OR = 12.0, p = 0.02), constipation (OR = 5.5, p = 0.01) and ocular dryness symptoms (OR = 8.29, p = 0.04). Cognitive alteration was associated with cardiovascular symptoms (OR = 4.33, p = 0.03) and dysfunction (OR = 5.83, p = 0.02) as well as with constipation (OR = 5.38, p = 0.02). Axial motor impairment and rapid eye movement (REM) sleep behaviour disorder were not related to any of the autonomic complaint or dysfunction. Our results show that autonomic functions are affected in a heterogeneous pattern in Parkinson's disease, thereby suggesting that the progression of autonomic dysfunction follows an erratic rather than a stepwise progression.
自主神经症状是帕金森病患者常见的非运动性主诉。大量神经病理学研究表明,路易体和神经纤维,帕金森病的病理标志,广泛分布于外周自主神经系统和终末器官。然而,很少有研究全面探讨帕金森病自主神经功能障碍的症状和生理学。因此,我们对 45 例特发性帕金森病患者进行了前瞻性自主神经功能评估。使用问卷和功能测试评估自主神经成分(瞳孔运动、泪液、唾液、心血管、消化、泌尿、性功能和出汗功能以及皮肤敏感性)。进行皮肤活检以量化表皮内神经纤维密度。此外,所有患者均接受多导睡眠图和全面的神经心理学和神经学评估。自主神经成分的分析关联表明,自主神经症状和体征在患者中呈异质性分布。通过表皮内神经纤维密度量化评估的皮肤去神经支配仅与定量热感觉测试(OR=12.0,p=0.02)、便秘(OR=5.5,p=0.01)和眼部干燥症状(OR=8.29,p=0.04)相关。认知改变与心血管症状(OR=4.33,p=0.03)和功能障碍(OR=5.83,p=0.02)以及便秘(OR=5.38,p=0.02)相关。轴性运动障碍和快速眼动(REM)睡眠行为障碍与任何自主投诉或功能障碍均无关。我们的研究结果表明,帕金森病患者的自主功能呈异质性受影响,这表明自主神经功能障碍的进展是不规则的,而不是渐进的。